The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion

被引:73
作者
Kim, Nayoung
Saudemont, Aurore
Webb, Louise
Camps, Montserrat
Ruckle, Thomas
Hirsch, Emilio
Turner, Martin
Colucci, Francesco [1 ]
机构
[1] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England
[2] Merck Serono Res Ctr, Geneva, Switzerland
[3] Ctr Mol Biotechnol, Dipartimento Genet Biol & Biochim, Turin, Italy
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
D O I
10.1182/blood-2007-02-075366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The signal transduction pathways that lead activated natural killer (NK) cells to produce cytokines, releases cytotoxic granules, or do both, are not clearly dissected. For example, phosphoinositide 3-kinases (PI3Ks) are key players in the execution of both functions, but the relative contribution of each isoform is unknown. We show here that the catalytic isoform p110 delta, not p110 gamma, was required for interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and granulocyte macrophage colony-stimulating factor (GMCSF) secretion, whereas neither was necessary for cytotoxicity. Yet, when both p110 delta and p110 gamma isoforms were inactivated by a combination of genetic and biochemical approaches, cytotoxicity was decreased. NK-cell numbers were also affected by the lack of p110 delta but not p110 gamma and more severely so in mice lacking both subunits. These results provide genetic evidence that p110 delta is the dominant PI3K isoform for cytokine secretion by NK cells and suggest that PI3Ks cooperate during NK-cell development and cytotoxicity.
引用
收藏
页码:3202 / 3208
页数:7
相关论文
共 45 条
[1]   Essential role for the p110δ phosphoinositide 3-kinase in the allergic response [J].
Ali, K ;
Bilancio, A ;
Thomas, M ;
Pearce, W ;
Gilfillan, AM ;
Tkaczyk, C ;
Kuehn, N ;
Gray, A ;
Giddings, J ;
Peskett, E ;
Fox, R ;
Bruce, I ;
Walker, C ;
Sawyer, C ;
Okkenhaug, K ;
Finan, P ;
Vanhaesebroeck, B .
NATURE, 2004, 431 (7011) :1007-1011
[2]  
Athié-M V, 2000, EUR J IMMUNOL, V30, P1425, DOI 10.1002/(SICI)1521-4141(200005)30:5<1425::AID-IMMU1425>3.0.CO
[3]  
2-Q
[4]   Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Wynshaw-Boris, A ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968
[5]   Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Nussbaum, RL .
MAMMALIAN GENOME, 2002, 13 (03) :169-172
[6]   NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway [J].
Billadeau, DD ;
Upshaw, JL ;
Schoon, RA ;
Dick, CJ ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :557-564
[7]   FC RECEPTOR STIMULATION OF PHOSPHATIDYLINOSITOL 3-KINASE IN NATURAL-KILLER-CELLS IS ASSOCIATED WITH PROTEIN-KINASE C-INDEPENDENT GRANULE RELEASE AND CELL-MEDIATED CYTOTOXICITY [J].
BONNEMA, JD ;
KARNITZ, LM ;
SCHOON, RA ;
ABRAHAM, RT ;
LEIBSON, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1427-1435
[8]   Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis [J].
Camps, M ;
Rückle, T ;
Ji, H ;
Ardissone, V ;
Rintelen, F ;
Shaw, J ;
Ferrandi, C ;
Chabert, C ;
Gillieron, C ;
Françon, B ;
Martin, T ;
Gretener, D ;
Perrin, D ;
Leroy, D ;
Vitte, PA ;
Hirsch, E ;
Wymann, MP ;
Cirillo, R ;
Schwarz, MK ;
Rommel, C .
NATURE MEDICINE, 2005, 11 (09) :936-943
[9]   A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation [J].
Clayton, E ;
Bardi, G ;
Bell, SE ;
Chantry, D ;
Downes, CP ;
Gray, A ;
Humphries, LA ;
Rawlings, D ;
Reynolds, H ;
Vigorito, E ;
Turner, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :753-763
[10]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425